- Home
- HTB vs PHAR Comparison
HTB vs PHAR Comparison
Compare HTB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTB
- PHAR
- Stock Information
- Founded
- HTB 1926
- PHAR 1988
- Country
- HTB United States
- PHAR Netherlands
- Employees
- HTB N/A
- PHAR N/A
- Industry
- HTB
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- HTB
- PHAR Health Care
- Exchange
- HTB NYSE
- PHAR Nasdaq
- Market Cap
- HTB 597.7M
- PHAR 587.5M
- IPO Year
- HTB N/A
- PHAR N/A
- Fundamental
- Price
- HTB $34.29
- PHAR $8.62
- Analyst Decision
- HTB Buy
- PHAR Strong Buy
- Analyst Count
- HTB 1
- PHAR 3
- Target Price
- HTB $43.00
- PHAR $30.00
- AVG Volume (30 Days)
- HTB 42.3K
- PHAR 6.7K
- Earning Date
- HTB 04-23-2025
- PHAR 03-13-2025
- Dividend Yield
- HTB 0.35%
- PHAR N/A
- EPS Growth
- HTB N/A
- PHAR N/A
- EPS
- HTB 3.20
- PHAR N/A
- Revenue
- HTB $193,436,000.00
- PHAR $297,200,000.00
- Revenue This Year
- HTB N/A
- PHAR $8.26
- Revenue Next Year
- HTB N/A
- PHAR $9.73
- P/E Ratio
- HTB $10.69
- PHAR N/A
- Revenue Growth
- HTB 4.69
- PHAR 21.15
- 52 Week Low
- HTB $23.55
- PHAR $6.65
- 52 Week High
- HTB $38.99
- PHAR $11.30
- Technical
- Relative Strength Index (RSI)
- HTB N/A
- PHAR 48.81
- Support Level
- HTB N/A
- PHAR $8.03
- Resistance Level
- HTB N/A
- PHAR $8.85
- Average True Range (ATR)
- HTB 0.00
- PHAR 0.34
- MACD
- HTB 0.00
- PHAR -0.01
- Stochastic Oscillator
- HTB 0.00
- PHAR 51.73
About HTB HOMETRUST BANCSHARES INC
HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.